The Israel Institute for Biological Research and the Weizmann Institute of Science Have Signed a Memorandum of Understanding to Collaborate in the Fight Against Coronavirus
REHOVOT, ISRAEL—April 20, 2020—The Israel Institute for Biological Research and the Weizmann Institute of Science will join efforts in advancing research designed to develop ways to combat the coronavirus. A Memorandum of Understanding (MoU) between the two Institutes on this matter has been signed in recent days.
The neighboring Institutes are characterized by their unique excellence in their respective fields, and collaboration between the two is likely to promote synergy and accelerate the process that scientists hope will lead to a medical solution to the coronavirus. The Institute for Biological Research’s Director General, Prof. Shmuel Shapira, and the Weizmann Institute of Science’s Vice President for Technology Transfer, Prof. Irit Sagi, say that signing the MoU is an important milestone among the broad range of joint activities established between the two Institutes.
The Weizmann Institute of Science in Rehovot, Israel, is one of the world’s top-ranking multidisciplinary research institutions. The Institute’s 3,800-strong scientific community engages in research addressing crucial problems in medicine and health, energy, technology, agriculture, and the environment. Outstanding young scientists from around the world pursue advanced degrees at the Weizmann Institute’s Feinberg Graduate School. The discoveries and theories of Weizmann Institute scientists have had a major impact on the wider scientific community, as well as on the quality of life of millions of people worldwide.